Literature DB >> 21378486

Platelet-rich plasma therapy: a systematic literature review and evidence for clinical use.

Lauren H Redler1, Scott A Thompson, Stephanie H Hsu, Christopher S Ahmad, William N Levine.   

Abstract

Platelet-rich plasma (PRP) is an autologous blood-derived product with an increased concentration of platelets in plasma, which are used to deliver supraphysiological levels of growth factors. Platelet-rich plasma has been used in many fields, including oral, maxillofacial, and plastic surgery. Its use in sports medicine has been increasing after recent evidence and media publicity suggest that it may augment the treatment of muscle strains, as well as tendon and ligament healing. Basic science and animal studies show promising results, but high-level clinical trials have yet to prove its efficacy. With increasing media coverage on the use of PRP in athletes, it is paramount that orthopedic surgeons and sports medicine physicians understand the various methods of preparation and administration, potential clinical applications, and available clinical results to best counsel patients on its advantages and disadvantages.

Entities:  

Mesh:

Year:  2011        PMID: 21378486     DOI: 10.3810/psm.2011.02.1861

Source DB:  PubMed          Journal:  Phys Sportsmed        ISSN: 0091-3847            Impact factor:   2.241


  21 in total

Review 1.  Platelet-rich plasma and its derivatives as promising bioactive materials for regenerative medicine: basic principles and concepts underlying recent advances.

Authors:  Tomoyuki Kawase
Journal:  Odontology       Date:  2015-06-04       Impact factor: 2.634

Review 2.  Learning about PRP using cell-based models.

Authors:  Knut Beitzel; Mary Beth McCarthy; Ryan P Russell; John Apostolakos; Mark P Cote; Augustus D Mazzocca
Journal:  Muscles Ligaments Tendons J       Date:  2014-05-08

Review 3.  Current Concepts Review Update: Insertional Achilles Tendinopathy.

Authors:  Ruth L Chimenti; Chris C Cychosz; Mederic M Hall; Phinit Phisitkul
Journal:  Foot Ankle Int       Date:  2017-08-08       Impact factor: 2.827

4.  Platelet-rich plasma (PRP) treatment of sports-related severe acute hamstring injuries.

Authors:  Yannick Guillodo; Gwénaelle Madouas; Thomas Simon; Hermine Le Dauphin; Alain Saraux
Journal:  Muscles Ligaments Tendons J       Date:  2016-02-13

5.  PRP as a new approach to prevent infection: preparation and in vitro antimicrobial properties of PRP.

Authors:  Hongshuai Li; Bingyun Li
Journal:  J Vis Exp       Date:  2013-04-09       Impact factor: 1.355

Review 6.  Stem cell therapy for critical limb ischemia: what can we learn from cell therapy for chronic wounds?

Authors:  Caroline Jadlowiec; Robert A Brenes; Xin Li; Wei Lv; Clinton D Protack; Michael J Collins; Alan Dardik
Journal:  Vascular       Date:  2012-10-19       Impact factor: 1.285

7.  Platelet-rich therapy in the treatment of patients with hip fractures: a single centre, parallel group, participant-blinded, randomised controlled trial.

Authors:  Xavier L Griffin; Juul Achten; Nick Parsons; Matt L Costa
Journal:  BMJ Open       Date:  2013-06-25       Impact factor: 2.692

8.  Evaluating the effectiveness of local dexamethasone injection in pregnant women with carpal tunnel syndrome.

Authors:  Ali Reza Moghtaderi; Neda Moghtaderi; Amir Loghmani
Journal:  J Res Med Sci       Date:  2011-05       Impact factor: 1.852

9.  Platelet-rich plasma inhibits the apoptosis of highly adipogenic homogeneous preadipocytes in an in vitro culture system.

Authors:  Yoshitaka Fukaya; Masayuki Kuroda; Yasuyuki Aoyagi; Sakiyo Asada; Yoshitaka Kubota; Yoshitaka Okamoto; Toshinori Nakayama; Yasushi Saito; Kaneshige Satoh; Hideaki Bujo
Journal:  Exp Mol Med       Date:  2012-05-31       Impact factor: 8.718

10.  Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors.

Authors:  Paola Romina Amable; Rosana Bizon Vieira Carias; Marcus Vinicius Telles Teixeira; Italo da Cruz Pacheco; Ronaldo José Farias Corrêa do Amaral; José Mauro Granjeiro; Radovan Borojevic
Journal:  Stem Cell Res Ther       Date:  2013-06-07       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.